SCHEMBL13623257

SCHEMBL13623257

c1ccc2c(c1)CCc1cc(-c3ccc(-c4ccc5c(c4)CCc4ccccc4N5c4ccc5ccccc5c4)c4ccccc34)ccc1N2c1ccc2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
HPGD P15428 1/20 0.47
HSP90AA1 P07900 1/20 0.41
CYP11B1 P15538 7/20 0.40
CYP11B2 P19099 7/20 0.40
HTR3A P46098 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MET P08581 1/20 0.35
GSTP1 P09211 1/20 0.34
HTR3E A5X5Y0 1/20 0.33
HTR3B O95264 1/20 0.33
HTR5A P47898 1/20 0.33
HTR3D Q70Z44 1/20 0.33
HTR3C Q8WXA8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623259 0.90 ALDH1A1 (0.41) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13623251 0.89 HSP90AA1 (0.45) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13623260 0.85 HPGD (0.41) ALDH1A1HPGDCYP11B1CYP11B2MEN1
SCHEMBL13706120 0.80 ALDH1A1 (0.40) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13009227 0.79 CYP1A2 (0.39) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13009030 0.79 LMNA (0.38) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13009167 0.79 MET (0.40) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13428159 0.78 MET (0.39) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13009006 0.78 HPGD (0.45) ALDH1A1CYP2C9CYP2C19LMNACYP1A2
SCHEMBL13428311 0.77 CYP1A2 (0.39) ALDH1A1CYP2C9CYP2C19LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R ALDH1A1 379/4885CYP2C9 47/4885CYP2C19 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.